These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20054055)

  • 1. The case for integrated delivery systems.
    Guttler SD
    N Engl J Med; 2010 Jan; 362(1):86; author reply 86. PubMed ID: 20054055
    [No Abstract]   [Full Text] [Related]  

  • 2. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

  • 3. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
    Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolving conflicting laws and policy in integrated delivery systems development.
    Shaffer AD; Pavarini PA
    J Law Health; 1997-1998; 12(1):85-120. PubMed ID: 10182031
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
    Marx D; Busey RC
    J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
    [No Abstract]   [Full Text] [Related]  

  • 6. Integration options.
    Williams L
    J Health Hosp Law; 1996; 29(2):88-96, 106. PubMed ID: 10160177
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitrust issues for hospice agencies.
    Mattson CW
    Caring; 1995 Nov; 14(11):43-5, 49-52. PubMed ID: 10154896
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
    Ewing KP; Koslov TI
    Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust and the developing continuum: advice for administrators, managers, and providers.
    Garrison P
    Continuum; 1998; 18(1):1, 3-6. PubMed ID: 10178903
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitrust concerns for physicians--not gone and not forgotten. Recent developments on the clinical integration front.
    Welch SS
    J Med Assoc Ga; 2009; 98(3):23-5. PubMed ID: 19714950
    [No Abstract]   [Full Text] [Related]  

  • 11. Government agencies soften stance on what constitutes price fixing.
    Ettinger DA; Lasser ML
    Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
    Wright R
    J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converting new antitrust guidance into action.
    Johnson BA
    Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Checkmate. Docs are pawns in game of creating integrated systems.
    Greene J
    Mod Healthc; 1997 Mar; 27(9):74, 76, 78-80. PubMed ID: 10165075
    [No Abstract]   [Full Text] [Related]  

  • 16. Revival of the fittest. PHOs have dropped in number, but many are still going strong despite antitrust scrutiny--and there's even renewed interest.
    Taylor M
    Mod Healthc; 2006 Jun; 36(26):24-6. PubMed ID: 16841648
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care mergers and acquisitions. How new federal laws prohibiting physician self-referrals affect integrated delivery systems.
    Homer LC
    Healthspan; 1994 Apr; 11(4):21-31. PubMed ID: 10134033
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing integrated delivery systems: an era of change in hospital-physician relationships.
    Hastings DA; Leopold A
    Physician Exec; 1992; 18(6):18-21. PubMed ID: 10122608
    [No Abstract]   [Full Text] [Related]  

  • 19. The antitrust risks of management services organizations, medical foundations, and integrated delivery systems.
    Rosch JT; Tada H
    Top Health Care Financ; 1994; 20(3):37-45. PubMed ID: 8191494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated delivery systems: reforming the conflicts among federal referral, tax exemption, and antitrust laws.
    Woodhall AL
    Health Matrix Clevel; 1995; 5(1):181-248. PubMed ID: 10141744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.